Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones. - Archive ouverte HAL Access content directly
Journal Articles Journal of Medicinal Chemistry Year : 2011

Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.

(1) , (1) , (2) , (2) , (2) , (1)
1
2

Abstract

Monoamine oxidases (MAOs) are involved in various psychiatric and neurodegenerative disorders; hence, MAO inhibitors are useful agents in the therapy of Parkinson's disease, Alzheimer's dementia, and depression syndrome. Herein we report a novel series of 3-(1H-pyrrol-3-yl)-2-oxazolidinones 3-7 as reversible, highly potent and selective anti-MAO-A agents. In particular, 4b, 5b, and 4c showed a K(i-MAO-A) of 0.6, 0.8, and 1 nM, respectively, 4c being 200000-fold selective for MAO-A with respect to MAO-B.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

pasteur-00980200 , version 1 (17-04-2014)

Identifiers

Cite

Sergio Valente, Stefano Tomassi, Giampiero Tempera, Stefania Saccoccio, Enzo Agostinelli, et al.. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.. Journal of Medicinal Chemistry, 2011, 54 (23), pp.8228-32. ⟨10.1021/jm201011x⟩. ⟨pasteur-00980200⟩

Collections

RIIP RIIP_FCB
16 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More